BRPI0416366A - composto, composições correspondentes, métodos de preparação e/ou de tratamento - Google Patents

composto, composições correspondentes, métodos de preparação e/ou de tratamento

Info

Publication number
BRPI0416366A
BRPI0416366A BRPI0416366-4A BRPI0416366A BRPI0416366A BR PI0416366 A BRPI0416366 A BR PI0416366A BR PI0416366 A BRPI0416366 A BR PI0416366A BR PI0416366 A BRPI0416366 A BR PI0416366A
Authority
BR
Brazil
Prior art keywords
preparation
methods
compound
treatment
corresponding compositions
Prior art date
Application number
BRPI0416366-4A
Other languages
English (en)
Inventor
Philip C Dell Orco
Ann Marie Die
Qiaogang Su
Jeffrey Lee Wood
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BRPI0416366A publication Critical patent/BRPI0416366A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTO, COMPOSIçõES CORRESPONDENTES, MéTODOS DE PREPARAçãO E/OU DE TRATAMENTO". é apresentada uma forma cristalina nova de pentaidrato de monocloridrato de topotecano, que é um pentaidrato de monocloridrato de 10-¢(dimetilamino) metil!-4-etil-4,9-diidroxi-1H-pirano¢3<39>, 4<39>: 6,7!indolizino ¢1,2-b!quinolina-3,14(4H,12H)diona, correspondendo a composições farmacêuticas, métodos de preparação e/ou uso dos mesmos para tratar doenças anti-viróticas e/ou relacionadas com câncer.
BRPI0416366-4A 2003-11-12 2004-11-12 composto, composições correspondentes, métodos de preparação e/ou de tratamento BRPI0416366A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51916003P 2003-11-12 2003-11-12
US52457403P 2003-11-24 2003-11-24
PCT/US2004/037626 WO2005046608A2 (en) 2003-11-12 2004-11-12 Novel compound, corresponding compositions, preparation and/or treatment methods

Publications (1)

Publication Number Publication Date
BRPI0416366A true BRPI0416366A (pt) 2007-03-13

Family

ID=34594951

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416366-4A BRPI0416366A (pt) 2003-11-12 2004-11-12 composto, composições correspondentes, métodos de preparação e/ou de tratamento

Country Status (16)

Country Link
US (2) US7754733B2 (pt)
EP (1) EP1689400A4 (pt)
JP (1) JP2007510751A (pt)
KR (1) KR20060122847A (pt)
CN (1) CN1913897B (pt)
AR (1) AR046579A1 (pt)
AU (1) AU2004289318B2 (pt)
BR (1) BRPI0416366A (pt)
CA (1) CA2545876A1 (pt)
IL (1) IL175369A (pt)
IS (1) IS8491A (pt)
MA (1) MA28179A1 (pt)
NO (1) NO20062616L (pt)
RU (1) RU2352572C2 (pt)
TW (1) TWI333492B (pt)
WO (1) WO2005046608A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
WO2007042799A1 (en) * 2005-10-10 2007-04-19 Cipla Limited Novel crystalline forms
US7547785B2 (en) * 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
US7977483B2 (en) * 2007-04-11 2011-07-12 Scinopharm Taiwan, Ltd. Process for making topotecan
NZ580516A (en) 2007-04-19 2012-02-24 Scinopharm Taiwan Ltd Crystalline forms of topotecan hydrochloride and processes for making the same
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
ITMI20072268A1 (it) 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione
KR20250008774A (ko) 2022-05-11 2025-01-15 셀진 코포레이션 T 세포 요법 및 그의 생산과 관련된 방법 및 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
DK0547165T3 (da) * 1990-09-28 2000-03-27 Smithkline Beecham Corp Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
ATE223417T1 (de) * 1996-12-19 2002-09-15 Reddy Research Foundation Wasserlösliche c-ring analoge des 20(s)- camphothecins
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
CA2461089A1 (en) * 2001-09-25 2003-04-03 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of 20(s)-camptothecins
US6482830B1 (en) * 2002-02-21 2002-11-19 Supergen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
WO2007042799A1 (en) 2005-10-10 2007-04-19 Cipla Limited Novel crystalline forms
US7547785B2 (en) 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
NZ580516A (en) 2007-04-19 2012-02-24 Scinopharm Taiwan Ltd Crystalline forms of topotecan hydrochloride and processes for making the same
ITMI20072268A1 (it) 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione

Also Published As

Publication number Publication date
WO2005046608A3 (en) 2005-11-03
CN1913897B (zh) 2010-08-11
WO2005046608B1 (en) 2005-12-29
AR046579A1 (es) 2005-12-14
NO20062616L (no) 2006-07-12
US8158645B2 (en) 2012-04-17
RU2006120422A (ru) 2007-12-27
TWI333492B (en) 2010-11-21
MA28179A1 (fr) 2006-09-01
TW200530250A (en) 2005-09-16
EP1689400A2 (en) 2006-08-16
WO2005046608A2 (en) 2005-05-26
US20070117832A1 (en) 2007-05-24
AU2004289318B2 (en) 2010-04-29
CA2545876A1 (en) 2005-05-26
IL175369A0 (en) 2008-04-13
JP2007510751A (ja) 2007-04-26
RU2352572C2 (ru) 2009-04-20
EP1689400A4 (en) 2006-12-27
CN1913897A (zh) 2007-02-14
IS8491A (is) 2006-05-30
KR20060122847A (ko) 2006-11-30
IL175369A (en) 2012-03-29
US7754733B2 (en) 2010-07-13
AU2004289318A1 (en) 2005-05-26
US20100210677A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
CY1110504T1 (el) Αναστολεις κινασης πρωτεϊνης
ATE517882T1 (de) Chinolinderivate
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BRPI0413452A (pt) composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
GB0022438D0 (en) Organic Compounds
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
ECSP066948A (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
MY133527A (en) Isoquinoline derivatives
BRPI0411092A (pt) benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos
BR0103210A (pt) Derivados de azabicicloalcano e suas utilizações terapêuticas
BRPI0416366A (pt) composto, composições correspondentes, métodos de preparação e/ou de tratamento
BRPI0513287A (pt) derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
PT1412332E (pt) Derivados de quinolina e sua utilizacao como agentes antitumorais
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
BRPI0414171A (pt) benzo[b]tiofenos halossubstituìdos com atividade inibidora de pi3k como agentes terapêuticos
BRPI0517100A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, método para preparar um composto, composição farmacêutica, e, métodos para tratar um paciente sofrendo de distúrbios e de deficiência

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/4738; C07D 491/22; A61P 35/00

Ipc: A61K 31/4738 (2011.01), C07D 491/22 (2011.01), A61

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 8A E 9A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A, 11A, 12A, 13A, 14A E 15A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.